
Keywords: Rheumatoid arthritis; Serious infection; Mannose binding lectin; Immune system; Risk factor; bDMARD; Biologic disease-modifying antirheumatic drug; COPD; Chronic obstructive pulmonary disease; CS; Corticosteroids; DMARD; Disease-modifying antirheumatic dr